S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:STAA

STAAR Surgical (STAA) Stock Forecast, Price & News

$59.64
0.00 (0.00%)
(As of 05/20/2022 04:00 PM ET)
Add
Compare
Today's Range
$56.64
$61.05
50-Day Range
$50.24
$85.00
52-Week Range
$49.03
$163.08
Volume
480,088 shs
Average Volume
512,859 shs
Market Capitalization
$2.85 billion
P/E Ratio
102.83
Dividend Yield
N/A
Beta
1.18
30 days | 90 days | 365 days | Advanced Chart
Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAAR Surgical logo

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:STAA
CUSIP
85231230
Employees
692
Year Founded
1982

Sales & Book Value

Annual Sales
$230.47 million
Cash Flow
$0.71 per share
Book Value
$5.78 per share

Profitability

Net Income
$24.50 million
Pretax Margin
15.06%

Debt

Price-To-Earnings

Miscellaneous

Free Float
46,090,000
Market Cap
$2.85 billion
Optionable
Optionable

Company Calendar

Last Earnings
5/04/2022
Today
5/20/2022
Next Earnings (Estimated)
8/03/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.56 out of 5 stars

Medical Sector

103rd out of 1,420 stocks

Ophthalmic Goods Industry

2nd out of 5 stocks

Analyst Opinion: 4.4Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -













STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

Is STAAR Surgical a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" STAAR Surgical stock.
View analyst ratings for STAAR Surgical
or view top-rated stocks.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for STAAR Surgical
.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings data on Wednesday, May, 4th. The medical instruments supplier reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.10 by $0.11. The medical instruments supplier earned $63.20 million during the quarter, compared to analysts' expectations of $60.53 million. STAAR Surgical had a trailing twelve-month return on equity of 12.78% and a net margin of 11.98%. The company's revenue was up 24.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.13 EPS.
View STAAR Surgical's earnings history
.

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical updated its FY 2022 earnings guidance on Monday, May, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $295.00 million-$295.00 million, compared to the consensus revenue estimate of $295.37 million.

What price target have analysts set for STAA?

6 Wall Street analysts have issued 12-month target prices for STAAR Surgical's shares. Their forecasts range from $87.00 to $150.00. On average, they expect STAAR Surgical's stock price to reach $101.67 in the next twelve months. This suggests a possible upside of 70.5% from the stock's current price.
View analysts' price targets for STAAR Surgical
or view top-rated stocks among Wall Street analysts.

Who are STAAR Surgical's key executives?
STAAR Surgical's management team includes the following people:
What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical CEO Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among STAAR Surgical's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.83%), Baillie Gifford & Co. (10.97%), Vanguard Group Inc. (10.65%), State Street Corp (3.28%), Palo Alto Investors LP (2.38%) and Geneva Capital Management LLC (1.91%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends for STAAR Surgical
.

Which institutional investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Ensign Peak Advisors Inc, Group One Trading L.P., TimesSquare Capital Management LLC, AIA Group Ltd, PDT Partners LLC, Qube Research & Technologies Ltd, and Northern Trust Corp. Company insiders that have sold STAAR Surgical company stock in the last year include Broadwood Partners, LP, Caren L Mason, Hans-Martin Blickensdoerfer, James E Francese, Keith Holliday, Patrick F Williams, and Samuel J Gesten.
View insider buying and selling activity for STAAR Surgical
or view top insider-selling stocks.

Which institutional investors are buying STAAR Surgical stock?

STAA stock was purchased by a variety of institutional investors in the last quarter, including Clearbridge Investments LLC, Geneva Capital Management LLC, Allianz Asset Management GmbH, Vanguard Group Inc., Next Century Growth Investors LLC, Fuller & Thaler Asset Management Inc., Defender Capital LLC., and Portolan Capital Management LLC.
View insider buying and selling activity for STAAR Surgical
or or view top insider-buying stocks.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $59.64.

How much money does STAAR Surgical make?

STAAR Surgical has a market capitalization of $2.85 billion and generates $230.47 million in revenue each year. The medical instruments supplier earns $24.50 million in net income (profit) each year or $0.579990 on an earnings per share basis.

How many employees does STAAR Surgical have?

STAAR Surgical employs 692 workers across the globe.

Does STAAR Surgical have any subsidiaries?

The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.

When was STAAR Surgical founded?

STAAR Surgical was founded in 1982.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is www.staar.com.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at [email protected], or via fax at 626-303-2962.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.